| For: | Niu ZY, Li SZ, Shi YY, Xue Y. Effect of gastric microbiota on quadruple Helicobacter pylori eradication therapy containing bismuth. World J Gastroenterol 2021; 27(25): 3913-3924 [PMID: 34321854 DOI: 10.3748/wjg.v27.i25.3913] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i25/3913.htm |
| Number | Citing Articles |
| 1 |
YiWen Zhang, Zhe Yuan. A review of current evidence and perspectives on the mechanisms and clinical significance of hypoxia-induced remodeling of the gastric microbiota-metabolism axis. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1846664
|
| 2 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Helicobacter pylori and gastric cancer: a critical approach to who really needs eradication. Exploration of Digestive Diseases 2024; doi: 10.37349/edd.2024.00043
|
| 3 |
Sung-Hsin Kuo, Kun-Huei Yeh, Chung-Wu Lin, Jyh-Ming Liou, Ming-Shiang Wu, Li-Tzong Chen, Ann-Lii Cheng. Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma. Cancers 2022; 14(4) doi: 10.3390/cancers14041005
|
| 4 |
Dongsheng Liu, Jinyun Wang, Yong Xie. Refractory Helicobacter pylori infection and the gastric microbiota. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.976710
|
| 5 |
Yunxiang Chu, Lin Jin, Yan Weng, Xiaochuan Liu. Alteration of serum levels of tumour necrosis factor-a (TNF-a), interleukin-6 (IL-6), C-reactive protein (CRP), gastrin (GAS) and motilin (MTL) after treatment in the Helicobacter pylori-positive gastric ulcer. Journal of Medical Biochemistry 2025; 44(7) doi: 10.5937/jomb0-55373
|
| 6 |
Stanislav Sitkin, Leonid Lazebnik, Elena Avalueva, Svetlana Kononova, Timur Vakhitov. Gastrointestinal microbiome and <i>Helicobacter pylori</i>: Eradicate, leave it as it is, or take a personalized benefit–risk approach?. World Journal of Gastroenterology 2022; 28(7): 766-774 doi: 10.3748/wjg.v28.i7.766
|
| 7 |
Maria Pina Dore, Rosangela Sau, Caterina Niolu, Marcello Abbondio, Alessandro Tanca, Stefano Bibbò, Mariafrancesca Loria, Giovanni Mario Pes, Sergio Uzzau. Metagenomic Changes of Gut Microbiota following Treatment of Helicobacter pylori Infection with a Simplified Low-Dose Quadruple Therapy with Bismuth or Lactobacillus reuteri. Nutrients 2022; 14(14) doi: 10.3390/nu14142789
|
| 8 |
Wei Zheng, Xiao-Rui He, Ji-Wei Zheng, Zhen-Ya Zhu, Di-Ya Ye, Xin-Yi Jia, Qian-Cheng Xu, Mi-Zu Jiang. Effects of Helicobacter pylori infection on gastric mucosal microbiota. World Journal of Pediatrics 2026; 22(5) doi: 10.1007/s12519-026-01050-5
|
| 9 |
Maged T. Elghannam, Moataz H. Hassanien, Yosry A. Ameen, Emad A. Turky, Gamal M. ELattar, Ahmed A. ELRay, Mohammed D. ELTalkawy. Helicobacter pylori and oral–gut microbiome: clinical implications. Infection 2024; 52(2) doi: 10.1007/s15010-023-02115-7
|
| 10 |
Ling Zhang, Ming Zhao, Xiangsheng Fu. Gastric microbiota dysbiosis and Helicobacter pylori infection. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1153269
|
| 11 |
Alia Albush, Fayez Yassine, Hassan Abbas, Aya Hanna, Esber Saba, Melhem Bilen. The impact of Helicobacter pylori infection and eradication therapies on gut microbiota: a systematic review of microbial dysbiosis and its implications in gastric carcinogenesis. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1592977
|
| 12 |
Tingting Yu, Tianyu Lu, Wei Deng, Danping Yao, Cheng He, Peng Luo, Jian Song. Microbiome and function alterations in the gastric mucosa of asymptomatic patients with Helicobacter pylori infection. Helicobacter 2023; 28(3) doi: 10.1111/hel.12965
|
| 13 |
Yujia Ke, Cheng Tan, Junhai Zhen, Weiguo Dong. Global status and trends of gastric cancer and gastric microbiota research: a bibliometric analysis. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1341012
|